Trial NCT01238133

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-03813
Secondary IDs: 2010C0043 8518 CDR0000687152 NCI-2011-03813 OSU 10011 OSU-OH007 P30CA016058 U01CA076576

Last trial update was posted on 2015-09-04

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide Albumin-Bound Paclitaxel Carboplatin Gamma Secretase Inhibitors and Modulators Paclitaxel

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Triple-Negative Breast Carcinoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID